Alimera Sciences, Inc.
Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular ed…
Drug Manufacturers - Specialty & Generic
US, Alpharetta [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Alimera Sciences, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDAlimera Sciences, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Alimera Sciences, Inc..
If you want to see a demo, head over to the financial segments of AAPL